Armata Pharmaceuticals (ARMP) Net Cash Flow: 2013-2024
Historic Net Cash Flow for Armata Pharmaceuticals (ARMP) over the last 12 years, with Dec 2024 value amounting to -$4.5 million.
- Armata Pharmaceuticals' Net Cash Flow rose 190.98% to $2.4 million in Q4 2018 from the same period last year, while for Dec 2018 it was $1.3 million, marking a year-over-year increase of 320.73%. This contributed to the annual value of -$4.5 million for FY2024, which is 185.02% down from last year.
- As of FY2024, Armata Pharmaceuticals' Net Cash Flow stood at -$4.5 million, which was down 185.02% from -$1.6 million recorded in FY2023.
- In the past 5 years, Armata Pharmaceuticals' Net Cash Flow registered a high of $9.3 million during FY2022, and its lowest value of -$4.5 million during FY2024.
- In the last 3 years, Armata Pharmaceuticals' Net Cash Flow had a median value of -$1.6 million in 2023 and averaged $1.1 million.
- Its Net Cash Flow has fluctuated over the past 5 years, first spiked by 1,359.15% in 2022, then plummeted by 185.02% in 2024.
- Over the past 5 years, Armata Pharmaceuticals' Net Cash Flow (Yearly) stood at $4.1 million in 2020, then crashed by 84.48% to $639,000 in 2021, then spiked by 1,359.15% to $9.3 million in 2022, then tumbled by 116.83% to -$1.6 million in 2023, then slumped by 185.02% to -$4.5 million in 2024.